JP Patent

JP4718465B2 — ビグアニドおよびチアゾリジンジオン誘導体を含む新規の医薬製剤

Assigned to アンドルックス ラボズ リミテッド ライアビリティ カンパニー · Expires 2011-07-06 · 15y expired

What this patent protects

Patent listed against metformin-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP4718465B2
Jurisdiction
JP
Classification
—
Expires
2011-07-06
Drug substance claim
No
Drug product claim
No
Assignee
アンドルックス ラボズ リミテッド ライアビリティ カンパニー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.